Seoul, South Korea

Se Nyun Kim

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Digital Genomics Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Se Nyun Kim. Retrieved from https://idiyas.com/inventor/se-nyun-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Se Nyun Kim: Innovator in Lung Cancer Diagnostics

Introduction

Se Nyun Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer detection. His innovative work has the potential to improve early diagnosis and treatment options for patients suffering from this serious illness.

Latest Patents

Se Nyun Kim holds a patent for "Markers for the diagnosis of lung cancer." This invention discloses a diagnostic marker that is specific for lung cancer. The patent also relates to a composition and a kit that includes an agent for measuring the presence of the marker. Furthermore, it outlines a method for diagnosing lung cancer using the composition or kit, showcasing his commitment to advancing medical technology.

Career Highlights

Currently, Se Nyun Kim is associated with Digital Genomics Inc., where he continues to work on innovative solutions in genomics and diagnostics. His expertise and dedication to research have positioned him as a key figure in the development of diagnostic tools that can save lives.

Collaborations

Se Nyun Kim collaborates with notable colleagues, including Jeong Ho Yoon and Jong Ho Park. Their combined efforts contribute to the advancement of research and development in the field of lung cancer diagnostics.

Conclusion

Se Nyun Kim's work in developing diagnostic markers for lung cancer exemplifies the impact of innovation in healthcare. His contributions are vital for improving patient outcomes and advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…